List view / Grid view

Alchemab Therapeutics Ltd



Let’s talk neuroscience with Michelle Sidor at SFN

29 November 2023 | By

Drug Target Review’s Taylor Mixides met with Dr Michelle Sidor, the Director of Neuroscience at Alchemab Therapeutics, and Dr Sifis Pediaditakis at the Society for Neuroscience event this November. This exclusive interview explores neuroscientific research and its pivotal role in steering the company toward future triumphs. Michelle highlights the dynamic…